Peter A. LeWitt

22.3k total citations
200 papers, 8.1k citations indexed

About

Peter A. LeWitt is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Peter A. LeWitt has authored 200 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Neurology, 40 papers in Cellular and Molecular Neuroscience and 27 papers in Physiology. Recurrent topics in Peter A. LeWitt's work include Parkinson's Disease Mechanisms and Treatments (125 papers), Neurological disorders and treatments (87 papers) and Botulinum Toxin and Related Neurological Disorders (39 papers). Peter A. LeWitt is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (125 papers), Neurological disorders and treatments (87 papers) and Botulinum Toxin and Related Neurological Disorders (39 papers). Peter A. LeWitt collaborates with scholars based in United States, United Kingdom and Canada. Peter A. LeWitt's co-authors include David A. Loeffler, Rajesh Pahwa, Alberto J. Espay, Robert A. Hauser, Stanley Fahn, Richard S. Burns, James R. Connor, Kelly E. Lyons, Paul Juneau and Mei Lü and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Peter A. LeWitt

196 papers receiving 7.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter A. LeWitt United States	48	5.0k	2.1k	1.2k	1.2k	809	200	8.1k
Ali Samii United States	46	4.6k 0.9×	2.3k 1.1×	944 0.8×	1.2k 1.0×	999 1.2×	107	8.1k
Heinz Reichmann Germany	50	4.5k 0.9×	1.8k 0.8×	1.1k 0.9×	2.2k 1.9×	722 0.9×	303	9.3k
Elan D. Louis United States	49	4.1k 0.8×	1.5k 0.7×	1.1k 0.9×	918 0.8×	909 1.1×	135	6.9k
Per Borghammer Denmark	45	4.4k 0.9×	1.5k 0.7×	1.5k 1.2×	998 0.9×	838 1.0×	164	7.0k
Thomas Müller Germany	42	4.1k 0.8×	1.9k 0.9×	733 0.6×	1.3k 1.1×	640 0.8×	251	6.7k
David Devos France	54	4.5k 0.9×	1.8k 0.8×	926 0.8×	2.6k 2.2×	965 1.2×	234	9.4k
Fabio Blandini Italy	50	3.6k 0.7×	3.0k 1.4×	1.5k 1.3×	2.0k 1.7×	484 0.6×	174	7.9k
Vladimir Kostić Serbia	53	6.4k 1.3×	3.4k 1.6×	1.1k 0.9×	1.8k 1.5×	1.4k 1.7×	369	10.4k
Manfred Gerlach Germany	44	2.6k 0.5×	2.0k 1.0×	1.1k 0.9×	1.7k 1.4×	595 0.7×	174	6.7k
Eng‐King Tan Singapore	50	5.6k 1.1×	2.0k 1.0×	1.1k 0.9×	1.8k 1.6×	967 1.2×	293	8.3k

Countries citing papers authored by Peter A. LeWitt

Since Specialization

Citations

This map shows the geographic impact of Peter A. LeWitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. LeWitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. LeWitt more than expected).

Fields of papers citing papers by Peter A. LeWitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. LeWitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. LeWitt. The network helps show where Peter A. LeWitt may publish in the future.

Co-authorship network of co-authors of Peter A. LeWitt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. LeWitt. A scholar is included among the top collaborators of Peter A. LeWitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. LeWitt. Peter A. LeWitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

LeWitt, Peter A., et al.. (2024). Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement Disorders. 39(3). 613–618. 5 indexed citations

Hauser, Robert A., Alberto J. Espay, Aaron Ellenbogen, et al.. (2023). IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease. JAMA Neurology. 80(10). 1062–1062. 20 indexed citations

LeWitt, Peter A., et al.. (2023). Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease. Journal of Parkinson s Disease. 13(4). 441–451. 5 indexed citations

LeWitt, Peter A., Jia Li, Kuan-Han Wu, & Mei Lü. (2022). Diagnostic metabolomic profiling of Parkinson's disease biospecimens. Neurobiology of Disease. 177. 105962–105962. 15 indexed citations

Hauser, Robert A., Nobutaka Hattori, Hubert H. Fernandez, et al.. (2021). Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. Journal of Parkinson s Disease. 11(4). 1663–1675. 26 indexed citations

Farbman, Eric S., Cheryl Waters, Peter A. LeWitt, et al.. (2020). A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease. Parkinsonism & Related Disorders. 81. 144–150. 15 indexed citations

Loeffler, David A., Jan Aasly, Peter A. LeWitt, & Mary P. Coffey. (2019). What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?. Journal of Parkinson s Disease. 9(3). 467–488. 10 indexed citations

Loeffler, David A., Andrea C. Klaver, Mary P. Coffey, Jan Aasly, & Peter A. LeWitt. (2016). Age-Related Decrease in Heat Shock 70-kDa Protein 8 in Cerebrospinal Fluid Is Associated with Increased Oxidative Stress. Frontiers in Aging Neuroscience. 8. 178–178. 16 indexed citations

Hampson, Neil B., Karl Kieburtz, Peter A. LeWitt, Mika Leinonen, & Martin I. Freed. (2016). Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations. International Journal of Neuroscience. 127(3). 276–284. 16 indexed citations

10.

Bhidayasiri, Roongroj, et al.. (2015). Effective Delivery of Apomorphine in the Management of Parkinson Disease. Clinical Neuropharmacology. 38(3). 89–103. 42 indexed citations

11.

Heldman, Dustin A., Alberto J. Espay, Peter A. LeWitt, & Joseph P. Giuffrida. (2014). Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease. Parkinsonism & Related Disorders. 20(6). 590–595. 128 indexed citations

12.

Elble, Rodger J., Cynthia Comella, Stanley Fahn, et al.. (2012). Reliability of a new scale for essential tremor. Movement Disorders. 27(12). 1567–1569. 168 indexed citations

13.

Camp, Dianne M., et al.. (2009). Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease. Journal of Neuroinflammation. 6(1). 17–17. 54 indexed citations

14.

Lorenzl, Stefan, David S. Albers, Peter A. LeWitt, et al.. (2003). Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. Journal of the Neurological Sciences. 207(1-2). 71–76. 130 indexed citations

15.

Shoulson, Ira, David Oakes, Stanley Fahn, et al.. (2002). Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Annals of Neurology. 51(5). 604–612. 200 indexed citations

16.

Connor, James R., Brian S. Snyder, Paolo Arosio, David A. Loeffler, & Peter A. LeWitt. (1995). A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains. Journal of Neurochemistry. 65(2). 717–724. 264 indexed citations

17.

Loeffler, David A., A. J. DeMaggio, Paul Juneau, et al.. (1994). Ceruoplasmin Is Increased in Cerebrospinal Fluid in Alzheimerʼs Disease but Not Parkinsonʼs Disease. Alzheimer Disease & Associated Disorders. 8(3). 190–197. 63 indexed citations

18.

LeWitt, Peter A., et al.. (1993). Symptomatic Anti-Parkinsonian Effects of Monoamine Oxidase-B Inhibition: Comparison of Selegiline and Lazabemide. Clinical Neuropharmacology. 16(4). 332–337. 19 indexed citations

19.

Berchou, Richard, et al.. (1990). Pharmacokinetic evaluation of erythromycin and caffeine administered with bromocriptine. Clinical Pharmacology & Therapeutics. 47(6). 694–697. 31 indexed citations

20.

LeWitt, Peter A.. (1988). Neuropharmacological Intervention with Motor System Aging. Annals of the New York Academy of Sciences. 515(1). 376–382. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact